Mingxiu Ju
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.
Journal: The Journal of pathology
Published: October 10, 2023
DNAJC8: a prognostic marker and potential therapeutic target for hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: September 06, 2023
Targeting the Cdc2-like kinase 2 for overcoming platinum resistance in ovarian cancer.
Journal: MedComm
Published: September 05, 2023
The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages.
Journal: Cancer cell international
Published: April 19, 2023
A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: February 02, 2023
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers.
Journal: Frontiers in immunology
Published: December 01, 2022
Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
Journal: Cancer science
Published: May 31, 2022
Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 01, 2019
Long non-coding RNA DLEU1 exerts an oncogenic function in non-small cell lung cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 19, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026